(19)
(11) EP 1 268 550 A2

(12)

(88) Date of publication A3:
02.05.2002

(43) Date of publication:
02.01.2003 Bulletin 2003/01

(21) Application number: 01929604.5

(22) Date of filing: 16.03.2001
(51) International Patent Classification (IPC)7: C07K 16/00, C07K 16/46, A61K 51/10, A61K 39/395, G01N 33/53
(86) International application number:
PCT/EP0104/716
(87) International publication number:
WO 0106/8708 (20.09.2001 Gazette 2001/38)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
LT LV RO SI

(30) Priority: 17.03.2000 DE 10013286
11.09.2000 GB 0022216

(71) Applicant: Boehringer Ingelheim Pharma KG
55216 Ingelheim am Rhein (DE)

(72) Inventors:
  • PARK, John-Edward
    88400 Biberach (DE)
  • GARIN-CHESA, Pilar
    88400 Biberach-Riss (DE)
  • PFIZENMAIER, Klaus
    75223 Tiefenbronn (DE)
  • MOOSMAYER, Dieter
    10179 Berlin (DE)
  • MERSMANN, Michael
    38118 Braunschweig (DE)
  • SCHMIDT, Alexej
    71229 Leonberg (DE)

   


(54) HUMAN FAP-ALPHA-SPECIFIC ANTIBODIES